|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C12N 15/113 | (2006.01) |
| (11) | Number of the document | 2852668 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13760133.2 |
| Date of filing the European patent application | 2013-07-12 | |
| (97) | Date of publication of the European application | 2015-04-01 |
| (45) | Date of publication and mention of the grant of the patent | 2016-04-27 |
| (46) | Date of publication of the claims translation | 2016-08-10 |
| (86) | Number | PCT/NL2013/050534 |
| Date | 2013-07-12 |
| (87) | Number | WO 2014/011053 |
| Date | 2014-01-16 |
| (30) | Number | Date | Country code |
| 201261670681 P | 2012-07-12 | US | |
| 201261718801 P | 2012-10-26 | US | |
| 13166465 | 2013-05-03 | EP | |
| 13172515 | 2013-06-18 | EP | |
| 13173818 | 2013-06-26 | EP |
| (72) |
DE BOER, Daniel Anton, NL
RITSEMA, Tita, NL
|
| (73) |
ProQR Therapeutics II B.V.,
Darwinweg 24, 2333 CR Leiden,
NL
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Oligonukleotidai, skirti sukelti pokyčius sekoje tikslinės RNR molekulės, esančios gyvoje ląstelėje |
| OLIGONUCLEOTIDES FOR MAKING A CHANGE IN THE SEQUENCE OF A TARGET RNA MOLECULE PRESENT IN A LIVING CELL |
| Payment date | Validity (years) | Amount | |
| 2017-06-22 | 5 | 115.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2018-07-12 |